Guangdong Marubi Biotechnology Co (SHSE:603983) Other Current Payables: ¥173 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603983 Guangdong Marubi Biotechnology Co Ltd SHSE:603983
79 GF Score
Price ¥29.34
GF Value ¥45.39
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Guangdong Marubi Biotechnology Co Other Current Payables?

Guangdong Marubi Biotechnology Co SHSE:603983 +1.91% 79 Other Current Payables is ¥173 Mil as of Mar. 2026. GuruFocus rates SHSE:603983 with a GF Score™ of 79/100 and a GF Value™ of ¥45.39 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Guangdong Marubi Biotechnology Co's Other Current Payables for the quarter that ended in Mar. 2026 was ¥173 Mil.

Guangdong Marubi Biotechnology Co's quarterly Other Current Payables declined from Sep. 2025 (¥430 Mil) to Dec. 2025 (¥243 Mil) and declined from Dec. 2025 (¥243 Mil) to Mar. 2026 (¥173 Mil).

Guangdong Marubi Biotechnology Co's annual Other Current Payables declined from Dec. 2023 (¥200 Mil) to Dec. 2024 (¥185 Mil) but then increased from Dec. 2024 (¥185 Mil) to Dec. 2025 (¥243 Mil).

Guangdong Marubi Biotechnology Co Other Current Payables Related Terms

Guangdong Marubi Biotechnology Co Other Current Payables Historical Data

* Premium members only.

The historical data trend for Guangdong Marubi Biotechnology Co's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangdong Marubi Biotechnology Co Other Current Payables Chart

Guangdong Marubi Biotechnology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 156.91 167.40 200.19 185.14 243.10

Guangdong Marubi Biotechnology Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 129.12 169.46 429.66 243.10 172.78
SHSE:603983
79GF Score
Guangdong Marubi Biotechnology Co Ltd SHSE:603983
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guangdong Marubi Biotechnology Co Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of ¥173 Mil mean?
Guangdong Marubi Biotechnology Co (SHSE:603983) has a Other Current Payables of ¥173 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Guangdong Marubi Biotechnology Co and its competitors.
Is Guangdong Marubi Biotechnology Co's Other Current Payables too high?
Guangdong Marubi Biotechnology Co's current Other Current Payables is ¥173 Mil. Overall, Guangdong Marubi Biotechnology Co has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Guangdong Marubi Biotechnology Co's Other Current Payables compare to PG and CL?
Guangdong Marubi Biotechnology Co's Other Current Payables of ¥173 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Consumer Packaged Goods company?
A good Other Current Payables depends on the Consumer Packaged Goods industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Guangdong Marubi Biotechnology Co and its competitors. Guangdong Marubi Biotechnology Co's current Other Current Payables is ¥173 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangdong Marubi Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Guangdong Marubi Biotechnology Co (SHSE:603983) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥45.39, compared to a current price of ¥29.34 — trading 35.4% below its estimated fair value. The current Other Current Payables is ¥173 Mil. Guangdong Marubi Biotechnology Co's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Guangdong Marubi Biotechnology Co (SHSE:603983), the current Other Current Payables is ¥173 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guangdong Marubi Biotechnology Co (SHSE:603983) Overvalued in 2026?

Based on GuruFocus' analysis, Guangdong Marubi Biotechnology Co stock appears to be undervalued. The current stock price of ¥29.34 is trading 35.4% below its estimated GF Value™ of ¥45.39. GuruFocus considers Guangdong Marubi Biotechnology Co to be Significantly Undervalued.

Key valuation signals for SHSE:603983:

  • Other Current Payables: ¥173 Mil
  • GF Value™: ¥45.39 vs. price of ¥29.34 (35.4% below fair value)
  • GF Score™: 79/100 with 5 warning signs

No single metric tells the full story. See the SHSE:603983 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guangdong Marubi Biotechnology Co Business Description

Address No. 92, Peihe Road, Building 2, Science City, High-tech Industrial Development Zone, Guangdong Province, Guangzhou, CHN, 510000
Guangdong Marubi Biotechnology Co Ltd is engaged in the research and development, design, production, sales and service of various types of cosmetics.
79GF Score

Get the complete analysis for SHSE:603983

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥29.34
Price
¥45.39
GF Value